Don E. Fowler is the President and CEO of Navaux. He has a Bachelor of Economics from Arkansas State University. He brings over 25 years of sales/sales management in the diagnostics industry with extensive experience in developing small company sales strategies and growth. Most recently he was Vice-President of Sales, Oncology at Bio-Reference Laboratories, Inc. (“BRLI”), which prior to its acquisition in 2015 by OPKO Health, Inc., a NYSE-listed company, was publicly traded on NASDAQ and was the third largest diagnostic laboratory in the U.S.
Prior to BRLI, Mr. Fowler was employed by Specialty Laboratories, Inc. of Santa Monica, California. While at Specialty, he led sales team members in the launch of various LDTs related to infectious diseases. In his career, he has held various positions as National Accounts Director, Regional Sales Director, and Business Development Director. His career began with Doctors Pathology Services in Jonesboro, Arkansas offering diagnostic testing to clients throughout Arkansas until that firm was acquired by Quest Diagnostics in 1995. In January, 2016, Mr. Fowler was elected to the Board of Directors of Stage I Diagnostics.